Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Drug Injury
  • About Our Firm
  • Free Case Evaluation
  • Frequently Asked Questions

Expanding Treatment Options for Bleeds Related to Oral Anticoagulants

December 20, 2017 By Law Offices of Thomas J. Lamb, P.A.

UPDATE:  The FDA announced that it will push back its decision on whether to approve the reversal agent AndexXa to May 4, 2018.  The original review date was set for February 3, 2018, but the FDA wanted to consider additional information it had requested from Portola, the drug's manufacturer. (12/28/17).   Risk of Bleeding … [Read more...]

Filed Under: Unsafe Drugs Tagged With: ACC, American College of Cardiology, andexxa, antidotes, apixaban, bleeding reversal agents, dabigatran, direct oral anticoagulants, DOACs, edoxaban, Eliquis, FDA, major bleeding events, oral anticoagulants side effects, Pradaxa, Praxbind, rivaroxaban, Savaysa, Xarelto

New Anticoagulant BevyxXa Approved by the FDA

June 30, 2017 By Law Offices of Thomas J. Lamb, P.A.

On June 23, 2017, a new anticoagulant drug called BevyxXa (betrixaban) was approved by the FDA for the prevention of venous thromboembolism and pulmonary embolism. This drug acts as a direct Factor Xa inhibitor, similar to the other anticoagulant drugs Eliquis, Savaysa, and Xarelto. Unlike the anticoagulant Pradaxa, which is a direct … [Read more...]

Filed Under: Unsafe Drugs Tagged With: anticoagulants, betrixaban, bevyxxa, black-box drug label warning, bleeding risks, direct xa inhibitors, drug injury, drug injury lawsuits, drug side effects, Eliquis, FDA, NOACs, PE, Pradaxa, Pulmonary Embolism, Savaysa, venous thromboembolism, VTE, Xarelto

Eliquis MDL For Federal Lawsuits; In California, JCCP Petition Pending

February 14, 2017 By Law Offices of Thomas J. Lamb, P.A.

In the federal court system, there are now more than 50 Eliquis lawsuits filed, and more of these drug injury and death cases are expected. Given this situation, in early February 2017 the United States Judicial Panel on Multidistrict Litigation (JPML) established this consolidation of all federal court Eliquis cases, IN RE: ELIQUIS (APIXABAN) … [Read more...]

Filed Under: Unsafe Drugs Tagged With: drug injury lawsuits, Eliquis, Uncontrollable Bleeding Events

Defendants BMS And Pfizer Ask For Eliquis Federal Court Consolidation

November 11, 2016 By Law Offices of Thomas J. Lamb, P.A.

On October 13, 2016 attorneys for Bristol-Myers Squibb Company and Pfizer Inc. filed with the United States Judicial Panel on Multidistrict Litigation (JPML) this court document, “BRISTOL-MYERS SQUIBB COMPANY AND PFIZER INC.’S MOTION FOR TRANSFER OF RELATED ELIQUIS (APIXABAN) PRODUCTS LIABILITY ACTIONS FOR COORDINATED PRETRIAL PROCEEDINGS PURSUANT … [Read more...]

Filed Under: Unsafe Drugs Tagged With: bleeding events, bleeding risk, Eliquis, Gastrointestinal (GI) Bleeds, Uncontrollable Bleeding Events

Warfarin vs. Eliquis, Pradaxa, Xarelto, and Savaysa: Which is Better?

November 9, 2016 By Law Offices of Thomas J. Lamb, P.A.

There in an ongoing debate amongst medical professionals concerning the effectiveness and safety of warfarin in comparison to the non–vitamin K antagonist oral anticoagulants (NOACs)--such as Eliquis, Xarelto, Savaysa, and Pradaxa--for patients with atrial fibrillation. According to the Healio Cardiology today article, "Merits of warfarin, newer … [Read more...]

Filed Under: Unsafe Drugs Tagged With: anticoagulants, antidotes, bleeding events, blood thinners, drug injury, drug side effects, Eliquis, Gastrointestinal (GI) Bleeds, hemorrhagic strokes, intracranial hemorrhages, NOACs, Pradaxa, reversal agents, safety warnings, Savaysa, warfarin, Xarelto

Is Eliquis A Safe Alternative To Warfarin For Patients On Dialysis?

November 3, 2016 By Law Offices of Thomas J. Lamb, P.A.

In this article published online by Pharmacy Times in August 2016, “Is Apixaban Safe and Effective for Patients on Hemodialysis?”, Brandon Dyson, PharmD, BCPS, who is a clinical pharmacist at an academic medical center, puts some scrutiny on Eliquis, an increasingly popular blood-thinner drug: [Eliquis (apixaban)] is the only [novel oral … [Read more...]

Filed Under: Unsafe Drugs Tagged With: bleeding events, bleeding risk, Eliquis, Gastrointestinal (GI) Bleeds, Uncontrollable Bleeding Events

No Clinical Trials Comparing The Safety Of Eliquis To Xarelto Done Yet

October 26, 2016 By Law Offices of Thomas J. Lamb, P.A.

In two medical study reports it seemed that Xarelto (rivaroxaban) was more likely to be involved in a serious bleeding event as an adverse reaction than was either Pradaxa (dabigatran) or Eliquis (apixaban). Earlier this month the medical journal Chest published this article, “Direct comparison of dabigatran, rivaroxaban, and apixaban for … [Read more...]

Filed Under: Unsafe Drugs Tagged With: bleeding risk, Eliquis, Hemorrhages, Prad, Savaysa, Uncontrollable Bleeding Events, Xarelto

What’s in a Name? Debate on What to Call Novel Oral Anticoagulants

September 30, 2016 By Law Offices of Thomas J. Lamb, P.A.

Recently, controversy has arisen over what to call the novel oral anticoagulant class of drugs, which includes Pradaxa, Xarelto, Savaysa, and Eliquis.  The article "NOAC, DOAC, or TSOAC: What Should We Call Novel Oral Anticoagulants?" provides some interesting information about the different sides of this debate. Here is a list of the possible … [Read more...]

Filed Under: Unsafe Drugs Tagged With: anticoagulants, antidotes, bleeding events, blood thinners, DOAC, drug injury, Eliquis, FDA, Gastrointestinal (GI) Bleeds, hemorrhagic strokes, heparin, increased risks, intracranial hemorrhages, NOAC, ODI, Pradaxa, reversal agents, safety warnings, Savaysa, side effects, SODA, TSOAC, warfarin, Xarelto

Eliquis Lawsuits Being Filed Across The Country In Increasing Numbers

September 19, 2016 By Law Offices of Thomas J. Lamb, P.A.

It is important to know that as of September 2016 Eliquis does not currently have an FDA-approved antidote, or reversal agent, for a patient experiencing a trauma-induced bleeding event or needing emergency surgery. Eliquis (apixaban) was approved by the FDA in December 2012. These serious medical conditions have been associated with the use of … [Read more...]

Filed Under: Unsafe Drugs Tagged With: bleeding risk, Eliquis, Gastrointestinal (GI) Bleeds, Hemorrhages, Strokes, Uncontrollable Bleeding Events

Antidote Drug For Xarelto / Savaysa / Eliquis Is Denied FDA Approval

August 24, 2016 By Law Offices of Thomas J. Lamb, P.A.

The following Factor Xa inhibitors, which serve as blood-thinner drugs, are being used by an increasing number of patients for stroke prevention and for treatment of deep vein thrombosis and pulmonary embolism: Eliquis (apixaban) from Pfizer/Bristol-Myers Squibb; Xarelto (rivaroxaban) from Bayer/Johnson & Johnson; and, Savaysa … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Eliquis, Savaysa, Uncontrollable Bleeding Events, Xarelto

  • 1
  • 2
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Drug Injury Cases
  • Breast Implant Cases
  • Philips Breathing Devices Cases
  • GenX Cancer Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2022 · Law Offices of Thomas J. Lamb, P.A.